Antimalarial Drug Market by Mechanism of Action (Treatment for Malaria, Prevention from Malaria), Malaria Type, Drug Class, Distribution Channel, and Geography - Global Industry Analysis, Opportunities and Forecast up to 2028

Antimalarial Drug Market Size

The Antimalarial Drug market size was valued at $835.80 million in 2022 and is projected to reach $1,120.05 million by 2028, growing at a CAGR of 5.0% during the forecast period.

Antimalarial Drug Market Overview

An antimalarial drug is a medication specifically designed to prevent or treat malaria, a potentially life-threatening infectious disease caused by parasites transmitted through the bite of infected mosquitoes. These drugs work by targeting the malaria parasites (Plasmodium species) at various stages of their lifecycle, thereby preventing their replication and spread within the body. There are several classes of antimalarial drugs, each with different mechanisms of action and levels of effectiveness against specific species of malaria parasites. Commonly used antimalarial drugs include chloroquine, quinine, artemisinin-based combination therapies (ACTs), and mefloquine, among others. Some antimalarial drugs are used for prophylaxis to prevent malaria in individuals traveling to endemic areas, while others are used for the treatment of acute malaria infections. The choice of antimalarial drug depends on factors such as the species of malaria parasite prevalent in the region, drug resistance patterns, and the patient's medical history and tolerance. Despite the availability of various antimalarial drugs, the emergence of drug-resistant malaria strains poses a significant challenge to malaria control efforts, highlighting the ongoing need for research and development of new antimalarial agents.

Antimalarial Drug Market Dynamics

The market dynamics analyzed in this market research report encapsulate a multifaceted interplay of drivers and constraints that significantly shape the landscape of the Antimalarial Drug Market. The comprehensive analysis of both drivers and constraints enables a nuanced understanding of the market's dynamics, empowering businesses and stakeholders to make informed decisions in navigating the complexities of the market.

Antimalarial Drug Market Scope

The report “Global Antimalarial Drug Market: Industry Analysis, Opportunities and Forecast up to 2028” by Diligence Insights provides a detailed analysis of the present market and future outlook with market estimates and forecasts for all specified segments, encompassing both global and regional perspectives as outlined within the research framework. The study includes historical market data for the years 2020, 2021 and offers revenue estimations for 2022, and project forecasts spanning from 2023 to 2028. It places significant emphasis on the examination of market trends, key industry participants, supply chain developments, technological advancements, pivotal milestones, and prospective strategies. Comprehensive market assessments are carried out across major geographic regions, including North America, Europe, Asia Pacific, South America, and Middle East & Africa. As such, this report constitutes a valuable resource for current industry stakeholders, newcomers to the field, and potential investors.

The study offers an in-depth market analysis, drawing insights from industry experts across the value chain. A special focus has been made on 25 countries, including the United States, Canada, Mexico, the United Kingdom, Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, and South Africa, among others. The market data has been meticulously collected through extensive primary interviews and comprehensive secondary research. Market size determination is rooted in the revenue generated from sales across all the specified segments and sub-segments as defined within the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

Market Segmentation:

The research report includes in-depth coverage of the industry analysis with size, share, and forecast for the below segments:

Global Antimalarial Drug Market by, Mechanism of Action

·        Treatment for Malaria

·        Prevention from Malaria

Global Antimalarial Drug Market by, Malaria Type

·        Plasmodium Vivax

·        Plasmodium Ovale

·        Plasmodium Malariae

·        Plasmodium Falciparum

Global Antimalarial Drug Market by, Drug Class

·        Chloroquine

·        Mefloquine

·        Proguanil

·        Pyrimethamine

·        Quinine

·        Other Drug Classess

Global Antimalarial Drug Market by, Distribution Channel

·        E-Commerce

·        Hospital Pharmacy

·        Retail Pharmacy

Global Antimalarial Drug Market by, Geography

·        North America (The United States, Canada, Mexico), Market Estimates, Forecast & Opportunity Analysis.

·        Europe (Germany, France, UK, Italy, Spain, Rest of Europe), Market Estimates, Forecast & Opportunity Analysis

·        Asia Pacific (China, Japan, India, South Korea, Australia, New Zealand, Rest of Asia Pacific), Market Estimates, Forecast & Opportunity Analysis

·        South America (Brazil, Argentina, Chile, Rest of South America), Market Estimates, Forecast & Opportunity Analysis

·        Middle East & Africa (UAE, Saudi Arabia, Qatar, Iran, South Africa, Rest of Middle East & Africa), Market Estimates, Forecast & Opportunity Analysis.

Key Players Profiled in this Research Report include:

·        Alliance Pharma

·        Bayer

·        Cipla Inc

·        GlaxoSmithKline plc

·        Glenmark Pharmaceuticals

·        Hoffmann-La Roche Ltd

·        Ipca Laboratories Ltd

·        Mylan N.V.

·        Novartis AG

·        Pfizer Inc

·        Sanofi

·        Sun Pharmaceutical Industries Ltd.

What can be explored with this research report?

·        Understand global Antimalarial Drug Market analysis, trends, and forecast to 2028.

·        Understand analysis of the Antimalarial Drug Market structure by identifying various segments and sub-segments of the market.

·        Understand revenue forecast and strategic analysis concerning industry trends and contribution to the overall Antimalarial Drug Market.

·        Understand the revenue forecast of the Antimalarial Drug Market for North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

·        Identification of major market trends, factors driving, restraining, threatening, and providing opportunities for the Antimalarial Drug Market growth.

·        Analyzing opportunities by identification of high-growth segments/revenue pockets in the Antimalarial Drug Market.

·        Understand major player profiles in the Antimalarial Drug Market and analyze their business strategies.

·        Understand competitive developments such as joint ventures, alliances, mergers and acquisitions, and new product launches in the Antimalarial Drug Market.

Table Of Content

1 Market Introduction 
 1.1 Market Definition 
 1.2 Research Scope and Segmentation 
 1.3 Stakeholders 
 1.4 List of Abbreviations 
 
2 Executive Summary 
 
3 Research Methodology 
 3.1 Identification of Data 
 3.2 Evaluation of Market Dynamics 
 3.3 Collaboration of Data 
 3.4 Verification and Analysis 
 3.5 Research Approach 
 3.6 Data Sources and Assumptions 
 
4 Market Dynamics 
 4.1 Market Drivers 
 4.2 Market Restraints 
 4.3 Market Opportunities 
 4.4 Market Challenges 
 4.5 Impact of COVID-19 on the Antimalarial Drug Market 
 
5 Porter's Five Force Analysis 
 5.1 Bargaining Power of Suppliers 
 5.2 Bargaining Power of Buyers 
 5.3 Threat of New Entrants 
 5.4 Threat of Substitutes 
 5.5 Competitive Rivalry in the Market 
 
6 Global Antimalarial Drug Market by, Mechanism of Action 
 6.1 Overview 
 6.2 Treatment for Malaria 
 6.3 Prevention from Malaria 
 
7 Global Antimalarial Drug Market by, Malaria Type 
 7.1 Overview 
 7.2 Plasmodium Vivax 
 7.3 Plasmodium Ovale 
 7.4 Plasmodium Malariae 
 7.5 Plasmodium Falciparum 
 
8 Global Antimalarial Drug Market by, Drug Class 
 8.1 Overview 
 8.2 Chloroquine 
 8.3 Mefloquine 
 8.4 Proguanil 
 8.5 Pyrimethamine 
 8.6 Quinine 
 8.7 Other Drug Classess 
 
9 Global Antimalarial Drug Market by, Distribution Channel 
 9.1 Overview 
 9.2 E-Commerce  
 9.3 Hospital Pharmacy 
 9.4 Retail Pharmacy 
 
10 Global Antimalarial Drug Market by, Geography 
 10.1 Overview 
 10.2 North America 
 10.2.1 US
 10.2.2 Canada
 10.2.3 Mexico
 10.3 Europe 
 10.3.1 Germany
 10.3.2 France
 10.3.3 UK
 10.3.4 Italy
 10.3.5 Spain
 10.3.6 Rest of Europe
 10.4 Asia Pacific 
 10.4.1 China
 10.4.2 Japan
 10.4.3 India
 10.4.4 South Korea
 10.4.5 Australia
 10.4.6 New Zealand
 10.4.7 Rest of Asia Pacific
 10.5 South America 
 10.5.1 Brazil
 10.5.2 Argentina
 10.5.3 Chile
 10.5.4 Rest of South America
 10.6 Middle East & Africa 
 10.6.1 UAE
 10.6.2 Saudi Arabia
 10.6.3 Qatar
 10.6.4 Iran
 10.6.5 South Africa
 10.6.6 Rest of Middle East & Africa
 
11 Key Developments 
 
12 Company Profiling 
 12.1 Alliance Pharma 
 12.1.1 Business Overview
 12.1.2 Product/Service Offering
 12.1.3 Financial Overview
 12.1.4 SWOT Analysis
 12.1.5 Key Activities
 12.2 Bayer 
 12.3 Cipla Inc. 
 12.4 GlaxoSmithKline plc 
 12.5 Glenmark Pharmaceuticals 
 12.6 Hoffmann-La Roche Ltd 
 12.7 Ipca Laboratories Ltd 
 12.8 Mylan N.V. 
 12.9 Novartis AG 
 12.10 Pfizer Inc 
 12.11 Sanofi 
 12.12 Sun Pharmaceutical Industries Ltd.